AKT1 and Parkinson disease: Recent studies have shown that brain insulin signaling can regulate neuronal survival through the mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase-protein kinase B (Akt) downstream pathways, and plays a role in PD pathogenesis.